Home > Insider Trading > Filing (0001093557-18-000240)

Filing Details

Accession Number:: 0001093557-18-000240
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-11-16 17:14:12
Reporting Period:: 2018-11-14

Accepted Time:: 2018-11-16 17:14:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1093557	Dexcom Inc	DXCM	Surgical & Medical Instruments & Apparatus (3841)	330857544

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1323190	K Andrew Balo	6340 Sequence Drive San Diego CA 92121	Evp, Reg. Strategy, Clinical	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2018-11-14	1,200	$141.25	81,905	No	4	S	Direct
Common Stock	Disposition	2018-11-14	800	$142.13	81,105	No	4	S	Direct
Common Stock	Disposition	2018-11-14	1,502	$143.88	79,603	No	4	S	Direct
Common Stock	Disposition	2018-11-14	1,498	$144.43	78,105	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

On June 14, 2018, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan.
This transaction was executed in multiple trades at prices ranging from $141.00 to $141.42. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Included in this number are 59,217 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 14,381 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019.
This transaction was executed in multiple trades at prices ranging from $142.00 to $142.53. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $143.10 to $144.07. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $144.23 to $144.50. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.